MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajt.2026.08.002

Медицинская библиотека · American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026

Marginal zone B cell targeting limits alloantigen availability to follicular dendritic cells and mitigates antibody-mediated rejection.

Gassen Rodrigo B, Liu Kaifeng, Ganchiku Yoshikazu, Lima Karina, Al Jurdi Ayman, Susztak Katalin, Magee Ciara N, Murakami Naoka, Rosales Ivy A, Borges Thiago J, Riella Leonardo V

СтатьяПеревод пока не подготовлен

Аннотация

Chronic antibody-mediated rejection is a leading cause of allograft loss, with limited therapies that effectively target humoral immunity. Current immunosuppressive regimens primarily target T cells, leaving a critical gap in strategies to suppress antibody-driven rejection. Marginal zone (MZ) B cells are innate-like cells that can rapidly generate antibodies, but their role in donor-specific antibody generation and chronic rejection remains unclear. We developed novel murine models of chronic antibody-mediated rejection using HLA-A2 transgenic heart and kidney transplants that recapitulate clinical features of human disease. Using an anti-Notch2 antibody to selectively target MZ B cells, we observed reduced antigen-specific humoral responses, including decreases in germinal center B cells, plasma cells, donor-specific antibodies, and C4d deposition, alongside improved graft structure and function. Mechanistically, the reduction of MZ B cells disrupted antigen shuttling to follicular dendritic cells, leading to decreased follicular dendritic cell-associated alloantigen clusters and impaired germinal center reactions. These findings establish MZ B cells as key drivers of alloantibody formation and highlight Notch2 as a promising therapeutic target.

Для цитирования: Gassen Rodrigo B, Liu Kaifeng, Ganchiku Yoshikazu, Lima Karina, Al Jurdi Ayman, Susztak Katalin, Magee Ciara N, Murakami Naoka, Rosales Ivy A, Borges Thiago J, Riella Leonardo V. Marginal zone B cell targeting limits alloantigen availability to follicular dendritic cells and mitigates antibody-mediated rejection.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2026. DOI: 10.1016/j.ajt.2026.08.002.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.